Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Equity Average (2021 - 2025)

Historic Equity Average for iSpecimen (ISPC) over the last 5 years, with Q3 2025 value amounting to $1.8 million.

  • iSpecimen's Equity Average fell 6580.22% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 6580.22%. This contributed to the annual value of $6.5 million for FY2024, which is 5656.58% down from last year.
  • Latest data reveals that iSpecimen reported Equity Average of $1.8 million as of Q3 2025, which was down 6580.22% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Equity Average ranged from a high of $28.7 million in Q1 2022 and a low of $1.1 million during Q2 2025
  • In the last 5 years, iSpecimen's Equity Average had a median value of $11.4 million in 2021 and averaged $13.1 million.
  • Per our database at Business Quant, iSpecimen's Equity Average surged by 10957.85% in 2022 and then tumbled by 8224.78% in 2025.
  • Quarter analysis of 5 years shows iSpecimen's Equity Average stood at $20.9 million in 2021, then rose by 2.03% to $21.4 million in 2022, then plummeted by 47.47% to $11.2 million in 2023, then plummeted by 64.25% to $4.0 million in 2024, then tumbled by 53.96% to $1.8 million in 2025.
  • Its Equity Average stands at $1.8 million for Q3 2025, versus $1.1 million for Q2 2025 and $2.5 million for Q1 2025.